Sarah Caton has been providing strategic consulting services to biopharma companies since 2015, and with Blue Matter since 2018. Her main areas of focus include brand strategy, launch planning, and medical affairs. Prior to joining Blue Matter, she worked in pricing and market access consulting at ICON, plc, and as a Health Research Analyst for The Economist Intelligence Unit. She earned an MSc in Public Health from the London School of Hygiene and Tropical Medicine, and a BA in Psychology from The George Washington University.